Search Results - "Litzky, L A"

Refine Results
  1. 1

    Evaluation of EGFR mutation status in cytology specimens: An institutional experience by Aisner, D. L., Deshpande, C., Baloch, Z., Watt, C. D., Litzky, L. A., Malhotra, B., Sepulveda, A. R., Langer, C., Evans, T., Van Deerlin, V. M.

    Published in Diagnostic cytopathology (01-04-2013)
    “…Epidermal growth factor receptor (EGFR) mutation status has been shown to predict response to anti‐EGFR tyrosine kinase inhibitors in non‐small cell lung…”
    Get full text
    Journal Article
  2. 2

    Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma by Vogel, J, Lin, L, Litzky, L.A, Berman, A.T, Simone, C.B

    “…Purpose Thymic malignanices are the most common tumors of the anterior mediastinum. The benefit of adjuvant radiation for stage II disease remains…”
    Get full text
    Journal Article
  3. 3

    Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas by YASHIMA, K, LITZKY, L. A, GAZDAR, A. F, KAISER, L, ROGERS, T, LAM, S, WISTUBA, I. I, MILCHGRUB, S, SRIVASTAVA, S, PIATYSZEK, M. A, SHAY, J. W

    Published in Cancer research (Chicago, Ill.) (15-06-1997)
    “…To investigate the role of telomerase in the multistage pathogenesis of lung cancer, we examined 205 fresh and archival tissue samples obtained from 40…”
    Get full text
    Journal Article
  4. 4

    Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma by Amin, KM, Litzky, LA, Smythe, WR, Mooney, AM, Morris, JM, Mews, DJ, Pass, HI, Kari, C, Rodeck, U, Rauscher, FJ, 3rd

    Published in The American journal of pathology (01-02-1995)
    “…The distinction between malignant mesothelioma and other neoplastic processes involving the pleura is difficult, partly due to the lack of specific markers…”
    Get full text
    Journal Article
  5. 5

    Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer by Hwang, H C, Smythe, W R, Elshami, A A, Kucharczuk, J C, Amin, K M, Williams, J P, Litzky, L A, Kaiser, L R, Albelda, S M

    “…Previous studies have shown adenoviral transfer of the herpes simplex virus thymidine kinase (HSVtk) gene followed by the anti-viral drug ganciclovir (GCV) can…”
    Get more information
    Journal Article
  6. 6

    Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation by Montone, Kathleen T., Litzky, Leslie A., Wurster, Angela, Kaiser, Larry, Bavaria, Joseph, Kotloff, Robert, Palevsky, Harold, Pietra, Giuseppe G., Tomaszewski, John E.

    Published in Surgery (01-05-1996)
    “…Background. Epstein-Barr virus (EBV)-associated posttransplantation lymphoproliferative disorder (PTLD) is a serious complication of lung transplantation…”
    Get full text
    Journal Article
  7. 7

    Successful Liver, Kidney, and Pancreas Transplantation From a Donor With Cerebral Emboli From a Left Atrial Myxoma by Canter, R.J., Abt, P.L., Litzky, L.A., Frank, A., Abt, A.B., Sellers, M.T., Markmann, J.F., Olthoff, K.M., Naji, A., Shaked, A.

    Published in Transplantation proceedings (01-12-2005)
    “…Although transmission and engraftment of donor-derived malignancies is rare in recipients of solid organ transplants, it is associated with unfavorable…”
    Get full text
    Journal Article
  8. 8

    Rapid method for detection of Aspergillus 5S ribosomal RNA using a genus-specific oligonucleotide probe by Montone, K T, Litzky, L A

    Published in American journal of clinical pathology (01-01-1995)
    “…Ribosomal RNA (rRNA) is present in all prokaryotic and eukaryotic cells. Although sequences are conserved, variations in nucleic acid composition are known to…”
    Get more information
    Journal Article
  9. 9

    Use of a replication-restricted herpes virus to treat experimental human malignant mesothelioma by KUCHARCZUK, J. C, RANDAZZO, B, LITZKY, L. A, FRASER, N. W, ALBELDA, S. M, KAISER, L. R, CHANG, M. Y, AMIN, K. M, ELSHAMI, A. A, STERMAN, D. H, RIZK, N. P, MOLNAR-KIMBER, K. L, BROWN, S. M, MACLEAN, A. R

    Published in Cancer research (Chicago, Ill.) (01-02-1997)
    “…Modified, nonneurovirulent herpes simplex viruses (HSVs) have shown promise in the treatment of brain tumors. However, HSV-1 can infect and lyse a wide range…”
    Get full text
    Journal Article
  10. 10

    Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma by Sterman, D H, Treat, J, Litzky, L A, Amin, K M, Coonrod, L, Molnar-Kimber, K, Recio, A, Knox, L, Wilson, J M, Albelda, S M, Kaiser, L R

    Published in Human gene therapy (01-05-1998)
    “…Malignant pleural mesothelioma is a fatal neoplasm that is unresponsive to standard modalities of cancer therapy. We conducted a phase I dose-escalation…”
    Get more information
    Journal Article
  11. 11

    The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene by ELSHAMI, A. A, KUCHARCZUK, J. C, STERMAN, D. H, SMYTHE, W. R, HWANG, H. C, AMIN, K. M, LITZKY, L. A, ALBELDA, S. M, KAISER, L. R

    Published in Annals of surgery (01-09-1995)
    “…To determine whether the immune system limits or improves the therapeutic efficacy of an adenovirus vector expressing the herpes simplex thymidine kinase…”
    Get full text
    Conference Proceeding Journal Article
  12. 12

    Cytokeratin immunoreactivity in malignant fibrous histiocytoma and spindle cell tumors: comparison between frozen and paraffin-embedded tissues by Litzky, L A, Brooks, J J

    Published in Modern pathology (01-01-1992)
    “…Cytokeratin (CK) immunoreactivity in malignant fibrous histiocytoma (MFH) and other selected cases of spindle cell tumors were assessed using two cytokeratin…”
    Get more information
    Journal Article
  13. 13

    Comparison of Molecular Changes in Lung Cancers in HIV-Positive and HIV-Indeterminate Subjects by Wistuba, Ignacio I, Behrens, Carmen, Milchgrub, Sara, Virmani, Arvind K, Jagirdar, Jaishree, Thomas, Bilue, Ioachim, Harry L, Litzky, Leslie A, Brambilla, Elisabeth M, Minna, John D, Gazdar, Adi F

    “…CONTEXT.— Human immunodeficiency virus (HIV) infection has been associated with an increasing incidence of malignancy, and HIV-infected persons have an…”
    Get full text
    Journal Article
  14. 14

    The pathology of fungal disease in the lung by Litzky, Leslie A.

    Published in Seminars in roentgenology (1996)
    “…The gross and histological appearance of pulmonary mycotic disease is rarely pathognomonic for a particular entity. Tissue obtained through an invasive…”
    Get full text
    Journal Article
  15. 15

    Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study by Goldman, M J, Litzky, L A, Engelhardt, J F, Wilson, J M

    Published in Human gene therapy (01-07-1995)
    “…This paper describes a preclinical toxicology study designed to investigate the biological efficacy and safety profile of second-generation adenovirus for CFTR…”
    Get more information
    Journal Article
  16. 16

    Bilateral sequential lung transplantation for pulmonary alveolar microlithiasis by Edelman, J D, Bavaria, J, Kaiser, L R, Litzky, L A, Palevsky, H I, Kotloff, R M

    Published in Chest (01-10-1997)
    “…Pulmonary alveolar microlithiasis (PAM) is characterized by deposition of calcium phosphate within the alveolar airspaces. There is currently no effective…”
    Get more information
    Journal Article
  17. 17

    Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene by Elshami, A A, Kucharczuk, J C, Zhang, H B, Smythe, W R, Hwang, H C, Litzky, L A, Kaiser, L R, Albelda, S M

    Published in Human gene therapy (20-01-1996)
    “…Previously, we have treated malignant mesothelioma (MM) growing in the peritoneal cavity of immunodeficient mice utilizing a recombinant adenovirus vector…”
    Get more information
    Journal Article
  18. 18

    Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates by Kucharczuk, J C, Raper, S, Elshami, A A, Amin, K M, Sterman, D H, Wheeldon, E B, Wilson, J M, Litzky, L A, Kaiser, L R, Albelda, S M

    Published in Human gene therapy (01-12-1996)
    “…Preclinical safety and toxicity studies of intrapleural administration of recombinant adenovirus carrying the herpes simplex thymidine kinase gene…”
    Get more information
    Journal Article
  19. 19

    Herpes simplex 1716--an ICP 34.5 mutant--is severely replication restricted in human skin xenografts in vivo by Randazzo, B P, Kucharczuk, J C, Litzky, L A, Kaiser, L R, Brown, S M, MacLean, A, Albelda, S M, Fraser, N W

    Published in Virology (New York, N.Y.) (15-09-1996)
    “…HSV-1716 is a replication-restricted, neuroattenuated ICP 34.5 gene mutant of herpes simplex virus type 1 (HSV-1). Because of the attenuated phenotype of ICP…”
    Get full text
    Journal Article
  20. 20

    Pleural-based mesothelioma in immune competent rats: A model to study adenoviral gene transfer by Kucharczuk, John C., Elshami, Ashraf A., Zhang, Hong Bing, Smythe, W. Roy, Hwang, Harry C., Tomlinson, James S., Amin, Kunjlata M., Litzky, Leslie A., Albelda, Steven M., Kaiser, Larry R.

    Published in The Annals of thoracic surgery (01-09-1995)
    “…Despite multimodality approaches, pleural-based malignant mesothelioma remains a disease with a very poor prognosis. Novel therapeutic strategies such as gene…”
    Get full text
    Journal Article